Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 246

1.

Influence of Lower Pole Infundibulopelvic Angle on Success of Retrograde Flexible Ureteroscopy and Laser Lithotripsy for the Treatment of Renal Stones.

Dresner SL, Iremashvili V, Best SL, Hedican SP, Nakada SY.

J Endourol. 2020 Mar 26. doi: 10.1089/end.2019.0720. [Epub ahead of print]

PMID:
31968995
2.

Stones, Space, and Dr. Abraham T. K. Cockett: A History of Urolithiasis and Aerospace Medicine.

Witthaus MW, Patel SR, Erturk ES, Nakada SY, Rabinowitz R.

Urology. 2020 Mar;137:9-13. doi: 10.1016/j.urology.2019.10.036. Epub 2019 Dec 5. No abstract available.

PMID:
31812579
3.

The effect of travel distance on health-related quality of life for patients with nephrolithiasis.

Narang GL, Wiener LE, Penniston KL, Antonelli JA, Averch TD, Sivalingam S, Chew BH, Bird VG, Pais VM Jr, Sur RL, Chi T, Streeper NM, Nakada SY, Koch GG, Viprakasit DP.

Can Urol Assoc J. 2020 Apr;14(4):99-104. doi: 10.5489/cuaj.6090. Epub 2019 Nov 5.

PMID:
31702546
4.

Comparing Outcomes for Patients with Clinical T1b Renal Cell Carcinoma Treated With Either Percutaneous Microwave Ablation or Surgery.

Shapiro DD, Wells SA, Best SL, Hedican SP, Ziemlewicz TJ, Lubner MG, Hinshaw JL, Lee FT Jr, Jarrard DF, Richards KA, Downs TM, Allen GO, Nakada SY, Abel EJ.

Urology. 2020 Jan;135:88-94. doi: 10.1016/j.urology.2019.09.024. Epub 2019 Oct 1.

PMID:
31585198
5.

Management of Indiana pouch stones through a percutaneous approach: A single center experience.

Öztürk M, McDermott JC, Laeseke PF, Nakada SY, Hedican SP, Best SL, Kleedehn MG.

Turk J Urol. 2019 Sep 1;45(5):366-371. doi: 10.5152/tud.2019.19049. Print 2019 Sep.

6.

Development of a Risk-stratified Approach for Follow-up Imaging After Percutaneous Thermal Ablation of Sporadic Stage One Renal Cell Carcinoma.

Dreyfuss LD, Wells SA, Best SL, Hedican SP, Ziemlewicz TJ, Lubner MG, Hinshaw JL, Lee FT Jr, Nakada SY, Abel EJ.

Urology. 2019 Dec;134:148-153. doi: 10.1016/j.urology.2019.08.022. Epub 2019 Aug 26.

PMID:
31465794
7.

The end of "Cutting for Stone"? Using the lithoclast trilogy for cystolitholapaxy on a 4 cm bladder stone per urethra.

Sninsky BC, Flamiatos JF, Nakada SY.

Urol Case Rep. 2019 Jul 10;26:100964. doi: 10.1016/j.eucr.2019.100964. eCollection 2019 Sep.

8.

Clinical and demographic predictors of repeat stone surgery.

Iremashvili V, Li S, Best SL, Hedican SP, Nakada SY.

BJU Int. 2019 Nov;124(5):836-841. doi: 10.1111/bju.14844. Epub 2019 Jun 30.

PMID:
31166648
9.

Association of Patient Age and Gender with Kidney Stone Related Quality of Life.

Stern KL, Gao T, Antonelli JA, Viprakasit DP, Averch TD, Chi T, Chew BH, Bird VG, Pais VM Jr, Streeper NM, Sur RL, Nakada SY, Penniston KL, Sivalingam S.

J Urol. 2019 Aug;202(2):309-313. doi: 10.1097/JU.0000000000000291. Epub 2019 Jul 8.

PMID:
31026215
10.

External Validation of the Recurrence of Kidney Stone Nomogram in a Surgical Cohort.

Iremashvili V, Li S, Penniston KL, Best SL, Hedican SP, Nakada SY.

J Endourol. 2019 Jun;33(6):475-479. doi: 10.1089/end.2018.0893. Epub 2019 Apr 23.

PMID:
30880452
11.

Low Income and Nonwhite Race are Strongly Associated with Worse Quality of Life in Patients with Nephrolithiasis.

Ahmad TR, Tzou DT, Usawachintachit M, Reliford-Titus S, Wu C, Goodman J, Antonelli JA, Viprakasit DP, Averch TD, Sivalingam S, Chew BH, Bird VG, Pais VM Jr, Streeper NM, Sur RL, Nakada SY, Penniston KL, Chi T.

J Urol. 2019 Jul;202(1):119-124. doi: 10.1097/JU.0000000000000233. Epub 2019 Jun 7.

PMID:
30865567
12.

Risk Factors for Complications and Nondiagnostic Results following 1,155 Consecutive Percutaneous Core Renal Mass Biopsies.

Posielski NM, Bui A, Wells SA, Best SL, Gettle LM, Ziemlewicz TJ, Lubner MG, Hinshaw JL, Lee FT Jr, Allen GO, Nakada SY, Abel EJ.

J Urol. 2019 Jun;201(6):1080-1087. doi: 10.1097/JU.0000000000000113.

PMID:
30741848
13.

Role of Residual Fragments on the Risk of Repeat Surgery after Flexible Ureteroscopy and Laser Lithotripsy: Single Center Study.

Iremashvili V, Li S, Penniston KL, Best SL, Hedican SP, Nakada SY.

J Urol. 2019 Feb;201(2):358-363. doi: 10.1016/j.juro.2018.09.053.

PMID:
30273609
14.

Ultra-low-dose limited renal CT for volumetric stone surveillance: advantages over standard unenhanced CT.

Planz VB, Posielski NM, Lubner MG, Li K, Chen GH, Nakada SY, Pickhardt PJ.

Abdom Radiol (NY). 2019 Jan;44(1):227-233. doi: 10.1007/s00261-018-1719-5.

PMID:
30073402
15.

The Effect of Thiazide and Potassium Citrate Use on the Health Related Quality of Life of Patients with Urolithiasis.

Raffin EP, Penniston KL, Antonelli JA, Viprakasit DP, Averch TD, Bird VG, Chew BH, Sivalingam S, Sur RL, Nakada SY, Pais VM Jr.

J Urol. 2018 Dec;200(6):1290-1294. doi: 10.1016/j.juro.2018.06.023. Epub 2018 Jun 18.

PMID:
29913138
16.

Updates in the Metabolic Management of Calcium Stones.

Penniston KL, Nakada SY.

Curr Urol Rep. 2018 Apr 16;19(6):41. doi: 10.1007/s11934-018-0791-2. Review.

PMID:
29663088
17.

Automated Computer Software Compared with Manual Measurements for CT-Based Urinary Stone Metrics: An Evaluation Study.

Bell JR, Posielski NM, Penniston KL, Lubner MG, Nakada SY, Pickhardt PJ.

J Endourol. 2018 May;32(5):455-461. doi: 10.1089/end.2017.0787. Epub 2018 Apr 2.

PMID:
29466878
18.

M.L. Gannon: Pioneer in Urology.

Patel SR, Best SL, Nakada SY.

Urology. 2018 Mar;113:10-12. doi: 10.1016/j.urology.2017.11.048. Epub 2017 Dec 26. No abstract available.

PMID:
29287976
19.

Comparative Analysis of Surgery, Thermal Ablation, and Active Surveillance for Renal Oncocytic Neoplasms.

Miller BL, Mankowski Gettle L, Van Roo JR, Ziemlewicz TJ, Best SL, Wells SA, Lubner MG, Hinshaw JL, Lee FT Jr, Nakada SY, Huang W, Abel EJ.

Urology. 2018 Feb;112:92-97. doi: 10.1016/j.urology.2017.09.016. Epub 2017 Oct 10.

PMID:
29030073
20.

Prospective evaluation of flexible ureteroscopes with a novel evaluation tool.

Bell JR, Penniston KL, Best SL, Nakada SY.

Can J Urol. 2017 Oct;24(5):9004-9010.

PMID:
28971788
21.

Randomized Controlled Trial Comparing Three Different Modalities of Lithotrites for Intracorporeal Lithotripsy in Percutaneous Nephrolithotomy.

York NE, Borofsky MS, Chew BH, Dauw CA, Paterson RF, Denstedt JD, Razvi H, Nadler RB, Humphreys MR, Preminger GM, Nakada SY, Krambeck AE, Miller NL, Terry C, Rawlings LD, Lingeman JE.

J Endourol. 2017 Nov;31(11):1145-1151. doi: 10.1089/end.2017.0436. Epub 2017 Nov 3.

PMID:
28859485
22.

Clinical use of patient decision-making aids for stone patients.

Lim AH, Streeper NM, Best SL, Penniston KL, Nakada SY.

Can J Urol. 2017 Aug;24(4):8890-8894.

PMID:
28832306
23.

In Vitro Comparison of Stone Fragmentation When Using Various Settings with Modern Variable Pulse Holmium Lasers.

Bell JR, Penniston KL, Nakada SY.

J Endourol. 2017 Oct;31(10):1067-1072. doi: 10.1089/end.2017.0351. Epub 2017 Aug 23.

PMID:
28728505
24.

In Vitro Comparison of Holmium Lasers: Evidence for Shorter Fragmentation Time and Decreased Retropulsion Using a Modern Variable-pulse Laser.

Bell JR, Penniston KL, Nakada SY.

Urology. 2017 Sep;107:37-42. doi: 10.1016/j.urology.2017.06.018. Epub 2017 Jun 21.

PMID:
28647563
25.

A survey of patient preferences regarding medical expulsive therapy following the SUSPEND trial.

Bell JR, Penniston KL, Best SL, Nakada SY.

Can J Urol. 2017 Jun;24(3):8827-8831.

26.

Use of the WISQOL Questionnaire.

Penniston KL, Nakada SY.

J Endourol. 2017 Apr;31(4):420. doi: 10.1089/end.2017.0017. Epub 2017 Mar 17. No abstract available.

PMID:
28306328
27.

Multi-quadrant biopsy technique improves diagnostic ability in large heterogeneous renal masses. Abel EJ, Heckman JE, Hinshaw L, Best S, Lubner M, Jarrard DF, Downs TM, Nakada SY, Lee FT Jr, Huang W, Ziemlewicz T.J Urol. 2015 Oct;194(4):886-91. [Epub 2015 Mar 30]. doi: 10.1016/j.juro.2015.03.106.

Jay R, Heckman JE, Hinshaw L, Best S, Lubner M, Jarrard DF, Downs TM, Nakada SY, Lee FT Jr, Huang W, Ziemlewicz T.

Urol Oncol. 2017 Mar;35(3):119. doi: 10.1016/j.urolonc.2016.12.025. Epub 2017 Feb 1.

PMID:
28159492
28.

The economics of stone disease.

Canvasser NE, Alken P, Lipkin M, Nakada SY, Sodha HS, Tepeler A, Lotan Y.

World J Urol. 2017 Sep;35(9):1321-1329. doi: 10.1007/s00345-017-2003-y. Epub 2017 Jan 20.

PMID:
28108799
29.

Effect of Tumor Complexity and Technique on Efficacy and Complications after Percutaneous Microwave Ablation of Stage T1a Renal Cell Carcinoma: A Single-Center, Retrospective Study.

Klapperich ME, Abel EJ, Ziemlewicz TJ, Best S, Lubner MG, Nakada SY, Hinshaw JL, Brace CL, Lee FT Jr, Wells SA.

Radiology. 2017 Jul;284(1):272-280. doi: 10.1148/radiol.2016160592. Epub 2017 Jan 11.

30.

Studies using a porcine model: what insights into human calcium oxalate stone formation mechanisms has this model facilitated?

Penniston KL, Patel SR, Schwahn DJ, Nakada SY.

Urolithiasis. 2017 Feb;45(1):109-125. doi: 10.1007/s00240-016-0947-9. Epub 2016 Nov 30. Review.

PMID:
27904915
31.

Validation and Reliability of the Wisconsin Stone Quality of Life Questionnaire.

Penniston KL, Antonelli JA, Viprakasit DP, Averch TD, Sivalingam S, Sur RL, Pais VM Jr, Chew BH, Bird VG, Nakada SY.

J Urol. 2017 May;197(5):1280-1288. doi: 10.1016/j.juro.2016.11.097. Epub 2016 Nov 23.

PMID:
27889419
32.
33.

Patients Attending Shared Medical Appointments for Metabolic Stone Prevention Have Decreased Stone Risk Factors.

Jhagroo RA, Nakada SY, Penniston KL.

J Endourol. 2016 Nov;30(11):1262-1268. Epub 2016 Oct 27.

PMID:
27673722
34.

A Critical Analysis of Perioperative Outcomes in Morbidly Obese Patients Following Renal Mass Surgery.

Grimes MD, Blute ML Jr, Wittmann TA, Mann MA, Zorn K, Downs TM, Shi F, Jarrard DF, Best SL, Richards KA, Nakada SY, Abel EJ.

Urology. 2016 Oct;96:93-98. doi: 10.1016/j.urology.2016.06.018. Epub 2016 Jun 23.

35.

Author reply.

Streeper NM, Nakada SY.

Urology. 2016 Jan;87:38-9. No abstract available.

PMID:
27243083
36.

Factors associated with patient recall of individualized dietary recommendations for kidney stone prevention.

Penniston KL, Wertheim ML, Nakada SY, Jhagroo RA.

Eur J Clin Nutr. 2016 Sep;70(9):1062-7. doi: 10.1038/ejcn.2016.79. Epub 2016 May 25.

PMID:
27222155
37.

Preliminary Evidence of Decreased Disease-Specific Health-Related Quality of Life in Asymptomatic Stone Patients.

Penniston KL, Sninsky BC, Nakada SY.

J Endourol. 2016 May;30 Suppl 1:S42-5. doi: 10.1089/end.2016.0074. Epub 2016 Mar 9.

PMID:
26864746
38.

Medical Expulsive Therapy is Useful for Urinary Calculi.

Preminger GM, Bell JR, Nakada SY.

J Urol. 2016 Mar;195(3):554-6. doi: 10.1016/j.juro.2015.12.066. Epub 2015 Dec 12. No abstract available.

PMID:
26690572
39.

Treatment expectations and health-related quality of life in stone formers.

Penniston KL, Nakada SY.

Curr Opin Urol. 2016 Jan;26(1):50-5. doi: 10.1097/MOU.0000000000000236. Review.

PMID:
26626885
40.

Extreme obesity does not predict poor cancer outcomes after surgery for renal cell cancer.

Blute ML Jr, Zorn K, Grimes M, Shi F, Downs TM, Jarrard DF, Best SL, Richards K, Nakada SY, Abel EJ.

BJU Int. 2016 Sep;118(3):399-407. doi: 10.1111/bju.13381. Epub 2015 Dec 22.

41.

Preliminary Evidence Suggests Periureteral Botulinum Toxin Type A Injection Improves Ureteral Stone Passage in the Porcine Model.

Streeper NM, Nakada SY, Wertheim ML, Best SL.

J Endourol. 2016 Mar;30(3):327-31. doi: 10.1089/end.2015.0249. Epub 2016 Jan 29.

PMID:
26560963
42.

The Use of Medical Expulsive Therapy During Pregnancy: A Worldwide Perspective Among Experts.

Lloyd GL, Lim A, Hamoui N, Nakada SY, Kielb SJ.

J Endourol. 2016 Mar;30(3):354-8. doi: 10.1089/end.2015.0587. Epub 2016 Jan 22.

PMID:
26482104
43.

Percutaneous Nephrolithotomy in Patients With BMI >50: Single Surgeon Outcomes and Feasibility.

Streeper NM, Radtke AC, Penniston KL, McDermott JC, Nakada SY.

Urology. 2016 Jan;87:33-9. doi: 10.1016/j.urology.2015.06.071. Epub 2015 Oct 9.

PMID:
26456745
44.

Does Combination Therapy with Tamsulosin and Tolterodine Improve Ureteral Stent Discomfort Compared with Tamsulosin Alone? A Double-Blind, Randomized, Controlled Trial.

Sivalingam S, Streeper NM, Sehgal PD, Sninsky BC, Best SL, Nakada SY.

J Urol. 2016 Feb;195(2):385-90. doi: 10.1016/j.juro.2015.08.104. Epub 2015 Sep 21.

PMID:
26393904
45.

Flexible ureteroscopic laser lithotripsy for upper urinary tract stone disease in patients with spinal cord injury.

Tepeler A, Sninsky BC, Nakada SY.

Urolithiasis. 2015 Nov;43(6):501-5. doi: 10.1007/s00240-015-0786-0. Epub 2015 May 19.

PMID:
25987450
46.

Multi-Quadrant Biopsy Technique Improves Diagnostic Ability in Large Heterogeneous Renal Masses.

Abel EJ, Heckman JE, Hinshaw L, Best S, Lubner M, Jarrard DF, Downs TM, Nakada SY, Lee FT Jr, Huang W, Ziemlewicz T.

J Urol. 2015 Oct;194(4):886-91. doi: 10.1016/j.juro.2015.03.106. Epub 2015 Mar 30.

PMID:
25837535
47.

Does socioeconomic status, age, or gender influence appointment attendance and completion of 24-hour urine collections?

Sninsky BC, Nakada SY, Penniston KL.

Urology. 2015 Mar;85(3):568-73. doi: 10.1016/j.urology.2014.10.043.

PMID:
25733267
48.

Contemporary Practice Patterns in the Management of Acute Obstructing Ureteral Stones.

Sivalingam S, Stormont IM, Nakada SY.

J Endourol. 2015 Jun;29(6):736-40. doi: 10.1089/end.2014.0681. Epub 2015 Mar 19.

PMID:
25608458
49.

Patient and tumor characteristics can predict nondiagnostic renal mass biopsy findings.

Prince J, Bultman E, Hinshaw L, Drewry A, Blute M, Best S, Lee FT Jr, Ziemlewicz T, Lubner M, Shi F, Nakada SY, Abel EJ.

J Urol. 2015 Jun;193(6):1899-904. doi: 10.1016/j.juro.2014.12.021. Epub 2014 Dec 11.

50.

Factors affecting outcomes of percutaneous nephrolithotomy in horseshoe kidneys.

Tepeler A, Sehgal PD, Akman T, Unsal A, Ozyuvali E, Armagan A, Nakada SY.

Urology. 2014 Dec;84(6):1290-4. doi: 10.1016/j.urology.2014.08.008. Epub 2014 Oct 7.

PMID:
25304208

Supplemental Content

Loading ...
Support Center